Sitapomin Alpha Tablet 50/500 mg

Adult dose

This medication is generally taken twice daily with food, and the dosage is gradually increased to reduce gastrointestinal side effects caused by metformin. 1. Patients not previously treated with metformin: - The initial dose is 1 tablet (50/500 mg) twice daily, with the possibility of increasing to 1 tablet (50/1000 mg) twice daily. 2. Patients currently on metformin treatment: - Recommended dosage

This medication can cause serious allergic reactions, although rare; therefore, if symptoms such as skin rash, shortness of breath, or swelling of the face or neck occur after administration, immediate discontinuation and consultation with a physician is advised. This medication can induce severe inflammation of the pancreas, known as pancreatitis; hence, if symptoms like abdominal pain, vomiting, or fever arise, medical personnel should be notified immediately. Patients with severely impaired renal function, acute heart failure, or severe infections should not use this medication, and it should particularly be discontinued before and after examinations involving contrast agents. It is safer not to use this medication in pregnant women or those who may become pregnant, as well as nursing mothers. Patients should be cautious of hypoglycemic symptoms while taking this medication, especially if it is used in combination with other antidiabetic agents as the risk of hypoglycemia may increase. The metformin component can rarely cause lactic acidosis, a life-threatening condition; hence, heightened caution is advised in cases of dehydration, severe infections, or heart disease. Patients should have regular kidney function and blood tests during the course of this medication, and it is advisable to monitor vitamin B12 levels as well. Alcohol consumption can increase the risk of side effects from this medication, so it is important to avoid excessive drinking while on this medication. In case of surgery or significant trauma, the medication should be temporarily discontinued, and it should be resumed only after the patient's condition stabilizes. When administering this medication to elderly patients, dosage adjustments must be made in consideration of renal function, and regular monitoring should be implemented to ensure safe management.

Serious side effects

• Hives, severe swelling (angioedema), anaphylaxis, severe allergic reactions
• High fever accompanied by severe rashes, Stevens-Johnson syndrome, exfoliative dermatitis
• Difficulty breathing, respiratory distress, respiratory issues
• Yellowing of the skin or eyes (jaundice), liver abnormalities
• Acute pancreatitis, fatal/non-fatal hemorrhagic or necrotizing pancreatitis
• Sudden and severe headaches, seizures, confusion, vision disturbances, paralysis
• Significantly decreased urine output,

Mild side effects

• Diarrhea
• nausea
• vomiting
• abdominal pain
• upper respiratory tract infections
• nasopharyngitis
• headache
• myalgia
• limb pain
• back pain

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance

Light pink oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]